Literature DB >> 17028127

Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.

O Höie1, L J Schouten, F L Wolters, I C Solberg, L Riis, I A Mouzas, P Politi, S Odes, E Langholz, M Vatn, R W Stockbrügger, B Moum.   

Abstract

BACKGROUND: Population based studies have revealed varying mortality for patients with ulcerative colitis but most have described patients from limited geographical areas who were diagnosed before 1990. AIMS: To assess overall mortality in a European cohort of patients with ulcerative colitis, 10 years after diagnosis, and to investigate national ulcerative colitis related mortality across Europe.
METHODS: Mortality 10 years after diagnosis was recorded in a prospective European-wide population based cohort of patients with ulcerative colitis diagnosed in 1991-1993 from nine centres in seven European countries. Expected mortality was calculated from the sex, age and country specific mortality in the WHO Mortality Database for 1995-1998. Standardised mortality ratios (SMR) and 95% confidence intervals (CI) were calculated.
RESULTS: At follow-up, 661 of 775 patients were alive with a median follow-up duration of 123 months (107-144). A total of 73 deaths (median follow-up time 61 months (1-133)) occurred compared with an expected 67. The overall mortality risk was no higher: SMR 1.09 (95% CI 0.86 to 1.37). Mortality by sex was SMR 0.92 (95% CI 0.65 to 1.26) for males and SMR 1.39 (95% CI 0.97 to 1.93) for females. There was a slightly higher risk in older age groups. For disease specific mortality, a higher SMR was found only for pulmonary disease. Mortality by European region was SMR 1.19 (95% CI 0.91 to 1.53) for the north and SMR 0.82 (95% CI 0.45-1.37) for the south.
CONCLUSIONS: Higher mortality was not found in patients with ulcerative colitis 10 years after disease onset. However, a significant rise in SMR for pulmonary disease, and a trend towards an age related rise in SMR, was observed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028127      PMCID: PMC1856843          DOI: 10.1136/gut.2006.101519

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Changes in the incidence of inflammatory bowel disease: what does it mean?

Authors: 
Journal:  Eur J Intern Med       Date:  2000-08       Impact factor: 4.487

2.  Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates.

Authors:  Frank L Wolters; Gilbert van Zeijl; Jildou Sijbrandij; Frederik Wessels; Colm O'Morain; Charles Limonard; Maurice G Russel; Reinhold W Stockbrugger
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 3.  Epidemiology of inflammatory bowel disease: an update.

Authors:  M G Russel; R W Stockbrügger
Journal:  Scand J Gastroenterol       Date:  1996-05       Impact factor: 2.423

4.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

5.  Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England.

Authors:  F Farrokhyar; E T Swarbrick; R H Grace; M D Hellier; A E Gent; E J Irvine
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

6.  Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study.

Authors:  C S Probert; V Jayanthi; A C Wicks; J F Mayberry
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

7.  Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

Authors:  Karen Vanessa Winther; Tine Jess; Ebbe Langholz; Pia Munkholm; Vibeke Binder
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis.

Authors:  T Bernklev; J Jahnsen; E Aadland; J Sauar; T Schulz; I Lygren; M Henriksen; N Stray; O Kjellevold; M Vatn; B Moum
Journal:  Scand J Gastroenterol       Date:  2004-04       Impact factor: 2.423

9.  Mortality in ulcerative colitis.

Authors:  S Gyde; P Prior; M J Dew; V Saunders; J A Waterhouse; R N Allan
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

10.  Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.

Authors:  G Masala; S Bagnoli; M Ceroti; C Saieva; G Trallori; I Zanna; G D'Albasio; D Palli
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

View more
  19 in total

1.  Current trends in inflammatory bowel disease: the natural history.

Authors:  Ebbe Langholz
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 2.  Natural history and complications of IBD.

Authors:  Morten H Vatn
Journal:  Curr Gastroenterol Rep       Date:  2009-12

Review 3.  Inflammatory bowel disease: a Canadian burden of illness review.

Authors:  Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

4.  Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

Authors:  Mathurin Fumery; Siddharth Singh; Parambir S Dulai; Corinne Gower-Rousseau; Laurent Peyrin-Biroulet; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

Review 5.  Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies.

Authors:  Magnus Hofrenning Wanderås; Bjørn A Moum; Marte Lie Høivik; Øistein Hovde
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

6.  Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism.

Authors:  Moshe Levy; Adi Rizansky
Journal:  Eur J Health Econ       Date:  2013-02-17

7.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

8.  IBD and IBD mimicking enterocolitis in children younger than 2 years of age.

Authors:  Z Cannioto; I Berti; S Martelossi; I Bruno; N Giurici; S Crovella; A Ventura
Journal:  Eur J Pediatr       Date:  2008-06-11       Impact factor: 3.183

9.  Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey.

Authors:  Laura Marín; Míriam Mañosa; Esther Garcia-Planella; Jordi Gordillo; Yamile Zabana; Eduard Cabré; Eugeni Domènech
Journal:  J Gastroenterol       Date:  2012-11-03       Impact factor: 7.527

Review 10.  How expensive is inflammatory bowel disease? A critical analysis.

Authors:  Selwyn Odes
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.